• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Brain Stimulation Lab

  • Home
  • People
    • Faculty
    • Postdocs
    • Staff
    • Collaborators
    • Alumni
  • Research
    • Clinical Trials
  • Publications
  • Training Opportunities
  • What is Neuromodulation?
  • For Patients
  • In the News
  • Support Our Research
    • Donate/Support
  • Contact Us

Brain Stimulation Lab

  • Home
  • People
    • Faculty
    • Postdocs
    • Staff
    • Collaborators
    • Alumni
  • Research
    • Clinical Trials
  • Publications
  • Training Opportunities
  • What is Neuromodulation?
  • For Patients
  • In the News
  • Support Our Research
    • Donate/Support
  • Contact Us
TwitterFacebook

News

In The News


For media inquiries, please visit the Contact Us page

The New Frontiers of Mental Health — Brain Stimulation, Rapid-Acting Tools for Depression, and More

January 6th, 2024


Dr. Nolan Williams: Psychedelics & Neurostimulation for Brain Rewiring

October 10, 2022


Psychiatry Online logo

Editor Spotlight: Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

February 2, 2022


A promising new treatment for depression

November 7, 2021


Psychiatry Online logo

A promising August 2020 AJP Editor Spotlight: Brain Stimulation Therapy for Treatment-Resistant Depression treatment for depression


Cutting Edge: Treating Depression Safely and Successfully


Featured

First on CNN: Noninvasive brain treatment for depression proves helpful

January 15, 2026


The Power Of Psychedelic Therapy For Members Of The Military

February 7, 2024

Stanford School of Medicine

Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets

January 5th, 2024 – By Sarah C.P. Williams

Psychedelic drug ibogaine shows preliminary promise for traumatic brain injury: Study

January 5th, 2024, by Angela Y. Zhang, MD

Stanford School of Medicine

Researchers treat depression by reversing brain signals traveling the wrong way

May 15th, 2023, by Nina Bai

A new therapy with magnets is helping people with depression when nothing else works

July 7, 2022, by Sarah Jacoby

Patrick J. Kennedy logo

A Moonshot for Inner Space

January 11, 2022, by Patrick J. Kennedy 

KQED logo

‘It Saved My Life’: Depression Treatment Is Turning Lives Around in Five Days

December 14th, 2021, by Lesley McClurg 

CBS News

SAINT: Hope for new treatment of depression

November 7th, 2021 

Magnetic Brain Stimulation Helped Rid Him of Decades-Long Depression

October 29th, 2021, by Cara Murez 

5-Day Brain Stimulation Treatment Highly Effective Against Depression, Stanford Researchers Find

October 29th, 2021, by Ed Cara

Stanford School of Medicine

Experimental depression treatment is nearly 80% effective in controlled study

October 28th, 2021, by Mandy Erickson

Pandemic spurs scientists to look closer at an experimental treatment for severe depression

January 21st, 2021

Remarkable Results in a Preliminary Clinical Test of a Rapid-Acting Antidepressant Treatment

August 11th, 2020

Remarkable Improvement Rate Reported in Patients Who Received SAINT, an Experimental Non-Invasive Brain-Stimulation Treatment for Resistant Depression

With the help of BBRF grants, researchers are testing a new treatment for people with major depression who have not responded to existing treatments. The first report of its effectiveness is very encouraging. Nolan R. Williams, M.D., Assistant Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, led a team that conducted a small, preliminary clinical test of a treatment protocol called the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treatment-resistant depression.

June 18th, 2020

Stanford researchers devise treatment that relieved depression in 90% of participants in small study

Published April 6th, 2020, by Mandy Erickson

Researchers Discover That Fast-Acting Antidepressant Ketamine Engages the Body’s Opioid System

October 2nd, 2018

New Research: Ketamine Activates Opioid System to Treat Depression; Experts Caution Against Widespread Use Due to Potential for Tolerance, Abuse and Dependence

August 29th, 2018, Washington D.C.

Ketamine May Ease Depression By Acting Like an Opioid, Study Suggests

August 29th, 2018, by Jamie Ducharne

Antidepressant ketamine might affect the brain like an opioid

August 29th, 2018, by Frankie Schembri

Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid

August 29th, 2018, by Jon Hamilton

What if Ketamine Actually Works Like an Opioid?

August 29th, 2018, by Matt Simon

Ketamine for depression may contribute to opioid dependence

August 29th, 2018, by Maria Cohut

Ketamine antidepressant could bring opioid-like addiction risks, study warns

August 29th, 2018, by Alex Matthews-King

Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in half a century

August 29th, 2018, by Erin Brodwin

Ketamine is emerging as a popular treatment for depression. New research suggests the drug acts like an opioid

August 29th, 2018, by Angelica LaVito

How Ketamine Treats Depression: It Acts Like an Opioid, Study Suggests

August 29th, 2018, by Rachael Rettner

Party Drug Ketamine Could Be Used to Treat Depression — But a New Study Says There’s a Risky Catch

August 29th, 2018, by Sy Mukherjee

Ketamine for Depression: How the Promising Antidepressant Drug Appears to Work like an Opioid

August 29th, 2018, by Kashmira Gander

Scientists May Have Unlocked the Secret of How Ketamine Treats Depression So Quickly

August 29th, 2018, by Ed Cara

Ketamine’s antidepressive effects tied to opioid system in brain, scientists say

August 29th, 2018, Stanford University Medical Center

Opioid system plays key role in ketamine’s antidepressant effects, Stanford study finds

August 29th, 2018, by Tracie White

Stanford School of Medicine

Ketamine’s antidepressive effects tied to opioid system in brain

August 28th, 2018, by Kimber Price

Ketamine may be helpful in treating depression, study shows

August 28th, 2018, by Italo M. Brown


Also in the News

Scope Blog

Intense magnetic stimulation could reduce severe depression, new study shows

Read Stanford Medicine’s SCOPE blog article about Dr. Williams’ pilot study on using accelerated TBS for treatment-resistant depression.

February 14th, 2018, by Tracie White

A New Psychiatry Subspecialty?

Read Medscape’s interview with Dr. Williams and others on the future of interventional psychiatry.

Medscape, May 30, 2013

Primary Sidebar

As Featured In

Today logo
CBS logo
npr logo
Wired
KQED logo
Stanford Medicine logo
American Psychiatric Association
Gizmodo logo
Brain & Behavior Research Foundation logo

Footer

Stanford Medicine logo

Make a Gift      More Information »

© 2026 Stanford University. All rights reserved

Twitter Facebook

  • Home
  • People
    ▼
    • Faculty
    • Postdocs
    • Staff
    • Collaborators
    • Alumni
  • Research
    ▼
    • Clinical Trials
  • Publications
  • Training Opportunities
  • What is Neuromodulation?
  • For Patients
  • In the News
  • Support Our Research
    ▼
    • Donate/Support
  • Contact Us